Visceral Leishmaniasis

 Introduction

Etiologic agent = Leishmania chagasi (new world) L.infantum (old world)

In humans, leishmaniasis occurs in 3 clinical forms: cutaneous, mucosal/mucocutaneous and visceral. Different species of the Leishmania protozoan parasite predominate in different parts of the world and tend to be associated with specific forms of leishmaniasis.

Visceral leishmaniasis ("Kala-azar") has become an important emerging disease in dogs and people throughout the developing world, but particularly throughout the Mediterranean countries, India and Latin America. Members of the L. donovani complex of organisms cause visceral leishmaniasis - in the Mediterranean region, L. infantum; in Latin America, L. chagasi.

In Latin America, L. chagasi is maintained in wild canid reservoirs in nature, with spill-over into domestic dogs via the sandfly vector. (Similarly, dogs are also suspected to be an important reservoir of Leishmania braziliensis and peruviana, the causative agents of primary cutaneous leishmaniasis in the Americas.)

(Cats, coyotes, foxes, horses and rodents can also be infected, but are rarely clinically affected.)

 Leishmaniasis topics
 (To view any of these topics, simply click on the appropriate subject.)

First Leishmaniasis topic